Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib + BSC vs Placebo + BSC in Advanced Non-Squamous NSCLC
NCT01529112Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of lenvatinib in non-small cell lung cancer (NSCLC), sponsored by Eisai Co., Ltd.. Started Nov 2011; status: completed.
02
Drugs
lenvatinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01529112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529112.